Physician Profile



(14 reviews)

Haejin In, MD, MPH, MBA,



(14 reviews)

  • Chief Diversity Officer
  • Associate Director for Diversity, Equity and Inclusion
  • Surgical Oncologist
  • Associate Professor of Surgery, Robert Wood Johnson Medical School
  • Associate Professor of Health, Behavior and Policy, Rutgers School of Public Health
Contact Information

To schedule a new patient appointment call 844-CANCERNJ (844-226-2376)
To schedule a follow-up appointment call 732-235-7615
For all other inquiries call 732-235-2465.

About Me

I am honored to join Rutgers Cancer Institute of New Jersey as a surgical oncologist specializing in upper gastrointestinal cancers, a cancer health services researcher, Chief Diversity Officer, and the Associate Director of Diversity, Equity and Inclusion for the Cancer Institute. I hold joint faculty position as Associate Professor of Surgery at Robert Wood Johnson Medical School, and Associate Professor of Health, Behavior and Policy at Rutgers School of Public Health. 

My clinical expertise and research interests are dedicated to improving the quality of care in the outcomes of gastrointestinal (GI) cancer patients, including stomach, esophageal, pancreas and peritoneal surface malignancies. Clinically, my focus has been in providing state-of-the-art, minimally invasive surgeries, particularity for stomach cancer, while adhering to the most rigorous of oncologic surgery principles to provide those with cancer the greatest chance of cure. In addition to complex surgical oncology training at the University of Chicago, I also I have obtained additional training in the oncologic principles and the surgery of gastric cancer with world-renowned surgeons at Seoul National University Hospital in Korea and Cancer Institute of Japanese Foundation for Cancer Research in Japan to provide the best in cancer care for my patients. 

As a cancer researcher, I am interested in developing and implementing strategies to improve gastric cancer outcomes in the US, reduce cancer mortality, improve outcomes in cancer surgery, and reduce disparities in health outcomes for gastrointestinal cancers. My ongoing work includes understanding the epidemiology of gastric cancer in minority populations the U.S., identifying high-risk biomarkers for early detection of gastric cancer, and developing strategies to effectively deploy gastric cancer screening for high-risk populations. My research also focuses on developing systems interventions to reduce disparities in the quality of cancer care, including the underuse of surgery for GI cancers in socioeconomically challenged persons and inappropriate triaging for cancer patients resulting from poor access to care. I have authored more than 50 peer-reviewed publications. My research has been funded by the National Institutes of Health, National Cancer Institute, Alliance for Clinical Trials in Oncology, and society grants, including the Society for Surgery of the Alimentary Track.

I am a member of national and international organizations including the American Association for Cancer Research, Alliance for Clinical Trials in Oncology, American Society of Clinical Oncology, Society of Surgical Oncology, American College of Surgeons, Association for Academic Surgery, Society for Surgery of the Alimentary Track, and International Gastric Cancer Association. I am involved with setting standards for cancer care, and serve as an expert panelist and key contributor for upper gastrointestinal cancers for the American Joint Committee on Cancer (AJCC), which develops the staging systems of the AJCC staging manual; and serve as a member of the Chicago Consensus Working Group which develops multidisciplinary recommendations for the management of peritoneal surface malignancies. 

I obtained my MD degree from Dongguk University in South Korea. I completed surgical residency training at Boston Medical Center in Boston, MA, followed by surgical oncology training at the University of Chicago in Chicago, IL. I have completed two research fellowships, one at the combined Harvard Medical School and its affiliated hospitals (Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital) and at the American College of Surgeons where I examined public health policy and quality improvement for cancer patients. I also hold a Masters in Public Health degree from Harvard School of Public Health and a Masters in Business Administration degree in Healthcare Management from Boston University. Prior to joining Rutgers Cancer Institute, I was at Albert Einstein College of Medicine where I was an Associate Professor of Surgery and Epidemiology and Population Health, and also held the position of Director, Surgical Resident Research at Montefiore Medical Center. 

Clinical Expertise

Stomach Cancer, Esophageal Cancer, Pancreas Cancer, Peritoneal Surface Malignancies.

Ratings and Reviews

5 Overall

Based on 14 reviews


Give easy to understand instruction


Spend enough time with you


Show respect for what you say


Provider listen carefully to you


Provider expl in way you understand

March 5, 2024

Dr. In is amazing. Made me feel comfortable, explained everything thoroughly & did not rush my appointment at all.


Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with your insurance company they are still a participating plan prior to receiving services or care. Each plan is different and some provide different levels of coverage that could make a difference in your out-of-pocket costs. It is always best for the patient receiving care to contact their insurance company to obtain more information.

  • Aetna
  • Amerigroup
  • Cigna
  • Consumer Health Plan
  • Horizon BCBS
  • Horizon NJ Health
  • Magnacare
  • Medicaid
  • Medicare
  • Multiplan
  • Oxford Health
  • Qualcare HMO
  • Qualcare PPO
  • United Community
  • United Healthcare
  • United Medicare
  • WellCare

Articles and Press